Linustedastat
Highest phase reached
Phase 2
Drug type
Small molecule
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Small molecule
- Drug name
- Linustedastat
- Molecular weight
- 453.53
- Structure (SMILES)
- C[C@]12CC[C@@H]3c4cccc(F)c4CC[C@H]3[C@@H]1[C@H](CCC(=O)Nc1ccc(F)cn1)C/C2=N/O
- linustedastat
- Linustedastat
- linustedastat [INN]
- LINUSTEDASTAT [USAN]
- linustedastat inn
- linustedastat usan
- og 6219
- OG-6219
- CAS registry numbers
- 2254299-48-2
- ChEMBL ID
- CHEMBL6068020
- InChIKey
- RMMVCLGAUPAFAI-QGKQEXNFSA-N
- FDA ingredient codes (UNII)
- PP3PLL7GZY
- 171390018
- 177639894
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -stat
- Hydrogen bond acceptors
- 4
- Hydrogen bond donors
- 2
- Polar surface area
- 74.58
- Calculated partition coefficient (ALogP)
- 5.69
- Calculated partition coefficient (XLogP)
- 4.7
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Rule-of-five violations
- 1
- Rotatable bonds
- 4
- Heavy atoms
- 33
- Molecular formula
- C26H29F2N3O2
- Monoisotopic mass
- 453.22278350
- Natural product
- No